期刊文献+

miR-495在骨肉瘤细胞中表达变化、对MG-63细胞增殖的影响及其机制 被引量:4

Expression of miR-495 in osteosarcoma cells and its effect on proliferation of MG-63 cells
在线阅读 下载PDF
导出
摘要 目的观察miR-495在骨肉瘤细胞中的表达变化及其对骨肉瘤MG-63细胞增殖的影响,并探讨可能的分子机制。方法采用real-time PCR法检测人骨肉瘤细胞系Saos-2、U20S、MG-63及人成骨细胞h FOB1.19中的miR-495。将MG-63细胞分为阴性对照组、miR-495 mimics组、miR-495 mimics+HMGA2组,分别转染mimics-NC、miR-495 mimics、miR-495 mimics+HMGA2表达质粒,转染24、48、72、96 h后,采用CCK-8法检测MG-63细胞增殖能力。应用靶基因在线预测数据库miRanda并结合基因的功能分析进行miR-495的靶基因预测。采用双荧光素酶报告实验验证miR-495与靶基因的结合位点。采用Western blotting法验证miR-495对高迁移率族蛋白A2(HMGA2)表达的靶向调控作用。结果 Saos-2、MG-63、U20S细胞中miR-495的相对表达量低于h FOB1.19细胞(P均<0.01)。转染48、72、96 h后miR-495 mimics组MG-63细胞OD值低于阴性对照组组,miR-495 mimics+HMGA2组MG-63细胞OD值高于miR-495 mimics组(P均<0.01)。双荧光素酶报告实验结果提示miR-495可与HMGA2的3'UTR区特异性结合,从而显著抑制荧光素酶活性。miR-495 mimics组MG-63细胞中HMGA2蛋白的相对表达量低于mimics-NC组,miR-495 mimics+HMGA2组MG-63细胞中HMGA2蛋白的相对表达量高于miR-495 mimics组(P均<0.01)。结论骨肉瘤细胞中miR-495的表达水平低于正常成骨细胞;上调miR-495表达后骨肉瘤细胞增殖受到抑制;miR-495可能通过靶向调控HMGA2表达从而抑制骨肉瘤细胞的增殖。 Objective To explore the changes in the miR-495 expression of the osteosarcoma cells,and its effect on the cell proliferation of osteosarcoma MG-63 cells as wells as the underlying molecular mechanism. Methods The miR-495 expression in the human osteosarcoma Saos-2,U20 S,and MG-63 cells,and human osteoblast h FOB1. 19 cells was detected by using real-time PCR. The MG-63 cells were divided into three groups: negative control group( transfected with mimics-NC),miR-495 mimics group( transfected with miR-495 mimics),miR-495 mimics + HMGA2 group( co-transfected with miR-495 mimics and HMGA2 expression plasmid). The proliferation of MG-63 cell was detected by using CCK-8 at24,48,72 and 96 h after transfection. Target gene online prediction database miRanda combined with gene functional analysis were used to predict the target genes of miR-495. The binding sites of miR-495 and target genes were confirmed by double luciferase reporter assay. Western blotting was used to verify the regulatory effect of miR-495 on high mobility group protein A2( HMGA2) expression. Results The relative expression of miR-495 in Saos-2,MG-63 and U20 S cells was lower than that in h FOB1. 19 cells( all P〈0. 01). The OD value of MG-63 cells in the miR-495 mimics group was lower than that in the negative control group,and the OD value of MG-63 cells in the miR-495 mimics + HMGA2 group was higher than that in miR-495 mimics group at 24,48,72 and 96 h after transfection( all P〈0. 01). Moreover,dual-luciferase reporter assay suggested that miR-495 directly bound with the 3'-UTR of HMGA2,and thus inhibited the luciferase activity. The relative expression of HMGA2 protein in MG-63 cells of the miR-495 mimics group was lower than that in the mimics-NC group,and the relative expression of HMGA2 protein in MG-63 cells of the miR-495 mimics + HMGA2 group was higher than that in miR-495 mimics group( all P〈0. 01). Conclusions The expression level of miR-495 in the osteosarcoma cells is lower than that in normal osteoblasts cells. Up-regulating the miR-495 expression inhibits the proliferation of osteosarcoma cells,and miR-495 may inhibit the proliferation of osteosarcoma cells by targeting HMGA2 expression.
作者 王美凤 邢国英 宫锦蕾 孙英华 夏海 王复超 张兆卿 WANG Meifeng;XING Guoying;GONG Jinlei;SUN Yinghua;XIA Hai;WANG Fuchao;ZHANG Zhaoqing(Yidu Central Hospital Affiliated to Weifang Medical University,Weifang 262500,China)
出处 《山东医药》 CAS 2018年第23期18-21,共4页 Shandong Medical Journal
基金 山东省医药卫生科技发展计划面上项目(2017WS174)
关键词 骨肉瘤 骨肉瘤细胞 微小RNA-495 细胞增殖 高迁移率族蛋白A2 osteosarcoma osteosarcoma cells microRNA495 cell proliferation high mobility group box protein A2
作者简介 王美凤(1979-),女,本科,主要研究方向:肿瘤的分子靶向治疗.E-mail:wangmeifengwf@yeah.net;通信作者:孙英华(1976-),男,博士,主要研究方向为骨肉瘤的分子靶向治疗.E-mail:qzydsyh@163.com
  • 相关文献

参考文献2

二级参考文献62

  • 1张旗,何湘君,潘秀英.RNA加尾和引物延伸RT-PCR法实时定量检测microRNA[J].北京大学学报(医学版),2007,39(1):87-91. 被引量:23
  • 2Salani R, Kurman RJ, Giuntoli R, et al. Assessment of TP53 mu- tation using purified tissue samples of ovarian serous cancers re- veals a higher mutation rate than previously reported and does not correlate with drug resistance[ J]. Int J Gynecol Cancer, 2008, 18(3) : 487 -491.
  • 3Mahajan A, Liu Z, Gellert L, et al. HMGA2 : a biomarker signifi- cantly overexpressed in high-grade ovarian serous cancer[ J]. Mod Pathol, 2010, 23(5) : 673 -681.
  • 4Wei JJ, Wu J, Luan C, et al. HMGA2: a potential biomarker complement to P53 for detection of early-stage high-grade papillary serous cancer in fallopian tubes[ J]. Am J Surg Pathol, 2010, 34 (1): 18-26.
  • 5Karst AM, Drapkin R. Ovarian cancer pathogenesis: a model in evolution[ J/OL]. J Oncol, 2010:932371 [ 2011-05-07 ]. http ://www. ncbi. nlm.nih.gov/pmc/articles/PMC2739011/? tool = pubmed.
  • 6Przybycin CG, Kurman RJ, Ronnett BM, et al. Are all pelvic (nonuterine) serous cancers of tubal origin? [ J]. Am J Surg Pathol, 2010, 34 (10) : 1407 - 1416.
  • 7Diniz PM, Carvalho JP, Baracat EC, et al. Fallopian tube origin of supposed ovarian high-grade serous cancers [ J ]. Clinics ( Sao Paulo), 2011, 66(1): 73-76.
  • 8Jarboe E, Folkins A, Nucci MR, et al. Serous carcinogenesis in the fallopian tube: a descriptive classification [ J ]. Int J Gynecol Pathol, 2008, 27 ( 1 ) : 1 - 9.
  • 9Levanon K, Crum C, Drapkin R. New insights into the pathogenc- sis of serous ovarian cancer and its clinical impact[ J]. J Clin On- col, 2008, 26(32): 5284-5293.
  • 10Gattas G J, Quade B J, Nowak RA, et al. HMGIC expression in human adult and fetal tissues and in uterine leiomyomata [ J ]. Genes Chromosomes Cancer, 1999, 25(4) : 316 -322.

共引文献5

同被引文献33

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部